Menu
Currency
GWAS Study

Genome-wide survival study identifies PARL as a novel locus for clinical progression and neurodegeneration in Alzheimer's disease.

Chen SD, Zhang W, Feng YW et al.

36870520 PubMed ID
GWAS Study Type
212975 Participants
59 Views
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

CS
Chen SD
ZW
Zhang W
FY
Feng YW
WB
Wu BS
YL
Yang L
ZY
Zhang YR
WH
Wang HF
GY
Guo Y
DY
Deng YT
FJ
Feng JF
CW
Cheng W
DQ
Dong Q
YJ
Yu JT
Chapter II

Abstract

Summary of the research findings

Variability exists in the trajectories of Alzheimer's disease (AD). We aimed to identify genetic modulators of clinical progression in AD.

1,158 European ancestry individuals

Chapter III

Study Statistics

Key metrics and study information

212975
Total Participants
GWAS
Study Type
Yes
Replicated
211,817 British ancestry individuals
Replication Participants
European
Ancestry
U.K.
Recruitment Country
Chapter IV

AI-Generated Summary

AI-generated by DNAGENICS

Independent AI summary of health and genetic findings from the published study

Important: This summary is AI-generated by DNAGENICS for informational purposes only. It was not created by, affiliated with, or endorsed by the researchers behind the original publication, and is based solely on that published research. It may contain errors or omissions. DNAGENICS disclaims all liability for any inaccuracies or consequences arising from use of this information. Verify all information against the original publication. This is not professional scientific review or medical advice.

AI Summary In Progress

Our AI-generated summary of this publication is being prepared. Please check back soon.